Institution
Ochsner Medical Center
Healthcare•New Orleans, Louisiana, United States•
About: Ochsner Medical Center is a healthcare organization based out in New Orleans, Louisiana, United States. It is known for research contribution in the topics: Population & Heart failure. The organization has 980 authors who have published 1159 publications receiving 49961 citations. The organization is also known as: Ochsner Hospital & Ochsner Foundation Hospital.
Papers published on a yearly basis
Papers
More filters
TL;DR: The possible utility of TAVR for the treatment of rheumatic aortic stenosis is suggested and the procedure's impact on patient care, safety, and efficacy is discussed.
9 citations
TL;DR: The articles that follow in this issue of Hypertension represent part of the proceedings of a special symposium, the “Second Workshop on Structure and Function of Large Arteries,” a program organized by Professor Michel Safar at the Lutetia Hotel in Paris on January 20 and 21, 1995.
Abstract: The articles that follow in this issue of Hypertension represent part of the proceedings of a special symposium, the “Second Workshop on Structure and Function of Large Arteries,” a program organized by Professor Michel Safar at the Lutetia Hotel in Paris on January 20 and 21, 1995. This workshop was organized in the context of a special Biomed Program of the European Community and corresponded also to an educational grant-in-aid by Servier Laboratories.
When Professor Safar contacted the journal over a year in advance to determine our interest in publishing this program, we initiated discussions with Professor Safar and …
8 citations
TL;DR: As these two cases represent the first reports of topiramate-induced macular neurosensory retinal detachment, clinicians should be aware of this potential ocular side effect when administering this medication.
8 citations
TL;DR: It is hypothesized that alvocidib, followed by cytarabine and mitoxantrone, may be preferentially active in those with MCL-1 dependence, and the findings from stage 1 of the Zella 201 trial, in which this biomarker assay is used to select for patients with MCA, are reported.
8 citations
TL;DR: A radiation transport code using the GEANT4 Monte Carlo toolkit to simulate pediatric patients undergoing CT examinations is created, and simulated and measured CTDI values were within an overall average of 6% of each other.
Abstract: The authors have created a radiation transport code using the GEANT4 Monte Carlo toolkit to simulate pediatric patients undergoing CT examinations. The focus of this paper is to validate their simulation with real-world physical dosimetry measurements using two independent techniques. Exposure measurements were made with a standard 100-mm CT pencil ionization chamber, and absorbed doses were also measured using optically stimulated luminescent (OSL) dosimeters. Measurements were made in air with a standard 16-cm acrylic head phantom and with a standard 32-cm acrylic body phantom. Physical dose measurements determined from the ionization chamber in air for 100 and 120 kVp beam energies were used to derive photon-fluence calibration factors. Both ion chamber and OSL measurement results provide useful comparisons in the validation of the Monte Carlo simulations. It was found that simulated and measured CTDI values were within an overall average of 6% of each other.
8 citations
Authors
Showing all 993 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Carl J. Lavie | 106 | 1135 | 49318 |
| Michael R. Jaff | 82 | 442 | 28891 |
| Michael F. O'Rourke | 81 | 451 | 35355 |
| Mandeep R. Mehra | 80 | 644 | 31939 |
| Richard V. Milani | 80 | 454 | 23410 |
| Christopher J. White | 77 | 621 | 25767 |
| Bruce A. Reitz | 74 | 333 | 18457 |
| Robert C. Bourge | 69 | 273 | 24397 |
| Sana M. Al-Khatib | 69 | 377 | 17370 |
| Hector O. Ventura | 66 | 478 | 16379 |
| Andrew Mason | 63 | 360 | 15198 |
| Aaron S. Dumont | 60 | 386 | 13020 |
| Philip J. Kadowitz | 55 | 379 | 11951 |
| David W. Dunn | 54 | 195 | 8999 |
| Lydia A. Bazzano | 51 | 267 | 13581 |